Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_assertion type Assertion NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_head.
- NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_assertion description "[In contrast, p47phox, nicotinamide adenine dinucleotide phosphate oxidase 1 and nicotinamide adenine dinucleotide phosphate oxidase organizer 1 expression were more restricted to the zone of initial damage or to lesions from patients with acute or early relapsing/remitting multiple sclerosis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_provenance.
- NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_assertion evidence source_evidence_literature NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_provenance.
- NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_assertion SIO_000772 22366799 NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_provenance.
- NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_assertion wasDerivedFrom befree-2016 NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_provenance.
- NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_assertion wasGeneratedBy ECO_0000203 NP963492.RA4eR61h6x4xcftSN4g41dCWCyUWbI3coCBobOHhDv-YU130_provenance.